Showing 621-630 of 1110 results for "".
- Clearside Biomedical Appoints Dr. George Lasezkay as Interim CEOhttps://modernod.com/news/clearside-biomedical-appoints-dr-george-lasezkay-as-interim-ceo/2476448/Clearside Biomedical announced that its board of directors has appointed biopharmaceutical executive George Lasezkay, Pharm.D., JD, to the position of interim Chief Executive Officer, effective immediately. Dr. Lasezkay, a current member of the Clearside Board of Directors, succeeds Daniel H. Whi
- Tenpoint Therapeutics Appoints Stephen S. Lane, MD, as Chief Medical Officerhttps://modernod.com/news/tenpoint-therapeutics-appoints-stephen-s-lane-md-as-chief-medical-officer/2486536/Tenpoint Therapeutics announced the appointment of Stephen S. Lane, MD, as Chief Medical Officer (CMO). In this role, Dr. Lane will join the company’s executive leadership team and oversee clinical development strategy, medical affairs, and pharmacovigilance. <
- Alimera Sciences Appoints David Dyer, MD, as Chief Retina Specialisthttps://modernod.com/news/alimera-sciences-appoints-david-dyer-md-as-chief-retina-specialist/2479222/Alimera Sciences has announced the expansion of its leadership team with the appointment of David Dyer, MD, as chief retina specialist, effective today. Dr. Dyer brings his extensive medical knowledge and business exp
- UK’s First TransForm Inlay Procedure Performed by Sheraz Daya, MDhttps://modernod.com/news/uks-first-transform-inlay-procedure-performed-by-sheraz-daya-md/2476668/The first patients in the UK have undergone the TransForm Corneal Allograft (TCA) procedure, which was performed by Sheraz Daya, MD, FACP, FACS, FRCS(Ed), FRCOphth. TCA is a new procedur
- Ophthalmic World Leaders (OWL) Names First MD President and Other Leadership Changes for 2026https://modernod.com/news/ophthalmic-world-leaders-owl-names-first-md-president-and-other-leadership-changes-for-2026/2484293/Ophthalmic World Leaders (OWL) announces the appointment of Renee Bovelle, MD, as its new President. OWL also welcomes three new members to its Board of Directors: Kevin M. Douglas, MD (Medical Director, Eye Care – Retina, AbbVie), Maáza Martin (S
- Geoff Tabin, MD, Co-Founder of Global NGO HCP Cureblindness, Steps Into New Rolehttps://modernod.com/news/geoff-tabin-md-co-founder-of-global-ngo-hcp-cureblindness-steps-into-new-role/2482314/Effective immediately, Geoff Tabin, MD, will step down as Board Chair of the global nonprofit HCP Cureblindness (Himalayan Cataract Project), but will maintain an active role on the Board as Medical Director. Long-time HCP volunteer and Board Member, Matt Oliva, MD, will lead HCP into its excitin
- Azura Ophthalmics Enrolls First Patient in Phase 3 Clinical Trial for AZR-MD-001 in Patients with MGDhttps://modernod.com/news/azura-ophthalmics-enrolls-first-patient-in-phase-3-clinical-trial-for-azr-md-001-in-patients-with-mgd/2482307/Azura Ophthalmics announced that the first patient has been enrolled in the ASTRO study—a phase 3 clinical trial assessing the efficacy and safety of AZR-MD-001 in patients with clinical signs and symptoms of meibomian gland dysfunction (MGD). "AZR-MD-001 has already dem
- More Than 1 Million People Have Recovered From COVID-19 Worldwidehttps://modernod.com/news/more-than-1-million-people-have-recovered-from-covid-19-worldwide/2477691/More than 1 million people around the world have recovered from COVID-19, according to data collected by Johns Hopkins University, as
- Julia Haller, MD, Named CEO of Wills Eye Hospitalhttps://modernod.com/news/julia-haller-md-named-ceo-of-wills-eye-hospital/2482897/Julia A. Haller, MD, Ophthalmologist-in-Chief at Wills Eye Hospital, will also become the hospital's next Chief Executive Officer. Dr. Haller assumed the expanded leadership post on July 18, succeeding longtime CEO Joseph P. Bilson, who reti
- Topcon Healthcare Appoints Daniela Ferrara, MD, PhD, as Chief Medical Officerhttps://modernod.com/news/topcon-healthcare-appoints-daniela-ferrara-md-phd-as-chief-medical-officer/2482764/Topcon Healthcare announced the appointment of Daniela Ferrara, MD, PhD, as its new Chief Medical Officer (CMO). In her new role, Dr. Ferrara will lead Topcon Healthcare’s global medical strategy, overseeing clinical r